Back
Day Range
$7.79
$8.12
52-Week Range
$2.60
$10.69
Volume
300,184
50D / 200D Avg
$7.57
/
$5.32
Prev Close
$7.75
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -35.6 | 0.4 |
| P/B | 4.6 | 2.9 |
| ROE % | -12.0 | 3.7 |
| Net Margin % | -3.6 | 3.9 |
| Rev Growth 5Y % | 7.6 | 10.0 |
| D/E | 0.4 | 0.2 |
Analyst Price Target
Hold
$6.80
-14.6%
Low: $5.00
High: $8.00
Forward P/E
31.6
Forward EPS
$0.25
EPS Growth (est.)
+0.0%
Est. Revenue
940 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$0.52
$0.52 – $0.53
|
1.1 B | 1 |
| FY2027 |
$0.34
$0.24 – $0.43
|
1 B | 2 |
| FY2026 |
$0.25
$0.21 – $0.30
|
940 M | 2 |
Key Takeaways
Revenue grew 7.56% annually over 5 years — modest growth
Debt/Equity of 0.43 — conservative balance sheet
Generating 26.60M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.20%
Capital efficient — spends only 0.73% of revenue on capex
Growth
Revenue Growth (5Y)
7.56%
Revenue (1Y)11.76%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-12.02%
ROIC-6.64%
Net Margin-3.55%
Op. Margin-3.49%
Safety
Debt / Equity
0.43
Current Ratio1.07
Interest Coverage-6.45
Valuation
P/E Ratio
-35.63
P/B Ratio4.60
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.76% | Revenue Growth (3Y) | 11.39% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7.56% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 853.70M | Net Income (TTM) | -30.31M |
| ROE | -12.02% | ROA | -5.44% |
| Gross Margin | 68.50% | Operating Margin | -3.49% |
| Net Margin | -3.55% | Free Cash Flow (TTM) | 26.60M |
| ROIC | -6.64% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.43 | Current Ratio | 1.07 |
| Interest Coverage | -6.45 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -35.63 | P/B Ratio | 4.60 |
| P/S Ratio | 1.27 | PEG Ratio | -0.44 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.08B | Enterprise Value | 1.12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 853.70M | 763.86M | 688.09M | 698.64M | 637.80M |
| Net Income | -30.31M | -21.34M | -40.67M | -6.52M | -43.99M |
| EPS (Diluted) | -0.22 | -0.16 | -0.30 | -0.05 | -0.33 |
| Gross Profit | 584.79M | 132.06M | 101.29M | 135.37M | 161.79M |
| Operating Income | -29.76M | -23.18M | -49.40M | -4.41M | 74.82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 557.23M | 579.84M | 547.66M | 562.87M | 538.61M |
| Total Liabilities | 294.32M | 280.03M | 247.85M | 209.13M | 180.65M |
| Shareholders' Equity | 234.97M | 269.26M | 269.26M | 332.36M | 334.56M |
| Total Debt | 101.08M | 113.04M | 113.04M | 84.81M | 82.63M |
| Cash & Equivalents | 64.14M | 56.96M | 56.95M | 184.45M | 203.70M |
| Current Assets | 176.11M | 173.14M | 173.14M | 240.96M | 250.93M |
| Current Liabilities | 164.81M | 138.60M | 138.60M | 105.31M | 78.57M |